Ceragenix and BexPharm Enter Into Distribution and Supply Agreement for EpiCeram(R)
22 févr. 2010 09h46 HE
|
Ceragenix Pharmaceuticals
DENVER, CO, Feb 22, 2010 -- Ceragenix Pharmaceuticals, Inc. ("Ceragenix") (OTCBB:CGXP), a medical device company focused on infectious disease and dermatology, today announced that it has entered...
Ceragenix and BioPro Enter into Distribution and Supply Agreement for EpiCeram(R)
07 janv. 2010 06h33 HE
|
Ceragenix Pharmaceuticals
DENVER, Jan 07, 2010 -- Ceragenix Pharmaceuticals, Inc. ("Ceragenix") (OTCBB:CGXP), a medical device company focused on infectious disease and dermatology today announced that it has entered into an...
Second Partner Exercises Option for Exclusive Period to Negotiate Licensing Terms for CeraShield(TM) Antimicrobial Coating Application
26 oct. 2009 06h46 HE
|
Ceragenix Pharmaceuticals
DENVER, Oct 26, 2009 -- Ceragenix Pharmaceuticals, Inc. ("Ceragenix" or the "Company") (OTCBB:CGXP), a medical device company focused on infectious disease and dermatology, today provided an update...
NIH Issues $2.87 Million Grant for Development of Ceragenin(TM)-Based Drug to Treat Clostridium difficile and Shigella Gastrointestinal Infections
09 sept. 2009 06h34 HE
|
Ceragenix Pharmaceuticals
DENVER, Sep 09, 2009 -- Ceragenix Pharmaceuticals, Inc. ("Ceragenix") (OTCBB:CGXP), a medical device company focused on infectious disease and dermatology, today announced that the National...
Partner Exercises Option for Exclusive Period to Negotiate Licensing Terms for CeraShield(TM) Antimicrobial Coating Application
01 sept. 2009 06h33 HE
|
Ceragenix Pharmaceuticals
DENVER, Sep 01, 2009 -- Ceragenix Pharmaceuticals, Inc. ("Ceragenix" or the "Company"), a medical device company focused on infectious disease and dermatology, today provided an update to a...
Ceragenix Completes Long-Term Antimicrobial Efficacy Test on Treated Silicone Medical Device
13 août 2009 06h58 HE
|
Ceragenix Pharmaceuticals
DENVER, Aug 13, 2009 -- Ceragenix Pharmaceuticals, Inc. (OTCBB:CGXP) (the "Company"), a medical device company focused on infectious disease and dermatology, today provided an update on its...
Ceragenix and Megapharm Enter Into Distribution and Supply Agreement for EpiCeram(R)
27 juil. 2009 07h21 HE
|
Ceragenix Pharmaceuticals
DENVER, Jul 27, 2009 -- Ceragenix Pharmaceuticals, Inc.("Ceragenix"), a medical device company focused on infectious disease and dermatology, today announced that it has entered into an exclusive...
Ceragenix and Nobel Biocare Enter into Option to License Agreement for Antimicrobial Technology
09 juil. 2009 07h07 HE
|
Ceragenix Pharmaceuticals
DENVER, Jul 09, 2009 -- Ceragenix Pharmaceuticals, Inc. (OTCBB:CGXP), a medical device company focused on infectious disease and dermatology, today announced that it has entered into an exclusive...
National Jewish Health and Ceragenix Announce Compound Shows Promise for Treating Potentially Lethal Viral Infections
22 juin 2009 07h15 HE
|
Ceragenix Pharmaceuticals
DENVER, Jun 22, 2009 -- Ceragenix Pharmaceuticals, Inc. ("Ceragenix") (OTCBB:CGXP), a medical device company focused on infectious disease and dermatology, today announced that researchers at...
Ceragenix and Davi Enter Into Distribution and Supply Agreement for EpiCeram(R)
19 mai 2009 07h12 HE
|
Ceragenix Pharmaceuticals
DENVER, May 19, 2009 -- Ceragenix Pharmaceuticals, Inc. ("Ceragenix") (OTCBB:CGXP), a medical device company focused on infectious disease and dermatology today announced that it has entered into an...